Alibaba CEO Wu Yongming Buys $4.98M in BABA Stock

Stock ticker graphic showing BABA with an insider buy transaction highlighted

A newly filed Form 4 shows Wu Yongming, Chief Executive Officer of Alibaba Group Holding Ltd (BABA), purchased 350,000 shares of the e-commerce and cloud computing giant on the open market on August 24, 2026. The transaction, paid for with Wu’s own funds rather than acquired through options or equity awards, was priced at $14.24 … Read more

SCTH Insider Sitra Scott Buys $100M in Open-Market Purchase

SEC Form 4 filing document showing an insider stock purchase by Sitra J Scott of Securetech Innovations

A newly filed Form 4 with the Securities and Exchange Commission shows Sitra J Scott, President, CEO, and a director of Securetech Innovations, Inc. (SCTH), purchased 1,000 shares of company stock on the open market on August 21, 2026. The filing lists a price of $100,000.00 per share, putting the total transaction value at $100,000,000.00. … Read more

Odysight.ai (ODYS) Director Arkin Buys $3.6M in Stock

Stock chart and SEC Form 4 filing document representing an insider stock purchase at Odysight.ai Inc.

A Form 4 filed with the SEC shows Moshe Arkin, a Director and 10%+ owner of Odysight.ai Inc. (NASDAQ: ODYS), purchased 1,125,000 shares of the company’s common stock on August 20, 2026. The transaction was an open-market buy, meaning Arkin used his own funds to acquire the shares at prevailing market prices rather than receiving … Read more

CCH Holdings (CCHH) CEO Goh Kok E Buys $1.44M in Stock

SEC Form 4 filing document showing an insider stock purchase by CCH Holdings executive Goh Kok E

A Form 4 filed with the SEC shows that Goh Kok E, who holds the titles of Chairman, CEO, COO and Director at CCH Holdings Ltd (CCHH), purchased 5,220,000 shares of the company on the open market on July 24, 2026. The purchase was made at $0.28 per share, for a total outlay of $1,440,720.00 … Read more

Walters Group Buys $15.2M in Zentalis Pharmaceuticals (ZNTL)

SEC Form 4 filing document showing an insider stock purchase in Zentalis Pharmaceuticals

A Form 4 filing with the Securities and Exchange Commission shows that Walters Group, a 10%+ owner of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL), purchased 4,335,000 shares of the company’s common stock on August 14, 2026. The transaction was an open-market purchase, meaning the insider used its own capital to acquire the shares rather than receiving … Read more

AB-Lend: 10% Owner PM Alpha II DAC Buys $1.3M in Shares

Stock ticker graphic representing AB Private Lending Fund insider share purchase disclosure

A newly filed Form 4 shows PM Alpha II DAC, a 10%-plus owner of AB Private Lending Fund (AB-Lend), purchased 53,060 shares of the fund on the open market on March 2, 2026. The transaction was priced at $24.99 per share, for a total outlay of $1,325,964.98. This was a straightforward open-market buy, meaning the … Read more

MLPT Insider Catalyst4 Buys $50M More Stock at $11.38

SEC Form 4 filing document showing an insider stock purchase at MapLight Therapeutics

Catalyst4, Inc., an insider at MapLight Therapeutics, Inc. (MLPT), disclosed a fresh open-market purchase in a Form 4 filing with the SEC. The transaction, dated August 14, 2026, shows Catalyst4 buying 4,400,000 shares at $11.38 apiece, a total outlay of $50,072,000.00 paid with the insider’s own funds. Following the purchase, Catalyst4 reports beneficial ownership of … Read more

Audax Private Credit Fund Insider Buys $14.1M in Shares

Illustration of SEC Form 4 filing documents showing an insider stock purchase disclosure

A filing with the SEC shows Audax Private Credit Business, LP, an insider of Audax Private Credit Fund, LLC, purchased 575,161 shares on the open market on August 12, 2026. The purchase price was $24.56 per share, for a total outlay of $14,124,234.89. Following the transaction, the insider’s indirect holdings, held through an entity structure … Read more

Intel CEO Tan Lip-Bu Buys $10M in INTC Shares at $95

SEC Form 4 filing details showing Intel CEO Tan Lip-Bu's open-market purchase of 105,263 shares at $95.00

Intel Corporation (NASDAQ: INTC) CEO and Director Tan Lip-Bu disclosed an open-market purchase of company stock in a Form 4 filing tied to a transaction dated August 11, 2026. The filing shows Tan bought 105,263 shares at $95.00 apiece, a purchase totaling $9,999,985.00 — just shy of the $10 million mark. Following the transaction, Tan’s … Read more

Outlook Therapeutics Insider Buys $2.5M in OTLK at $0.99

Illustration of an SEC Form 4 filing document with a stock chart for Outlook Therapeutics (OTLK)

A newly filed Form 4 shows Ghiath M. Sukhtian, an insider at Outlook Therapeutics, Inc. (OTLK), made a substantial open-market purchase of company stock. According to the filing, the transaction was dated August 12, 2026, and involved the purchase of 2,525,252 shares at a price of $0.99 per share, for a total outlay of $2,499,999.48. … Read more

BLSM Director Carl Gordon Buys $10M in Open-Market Purchase

SEC Form 4 filing document showing an insider stock purchase disclosure for BlossomHill Therapeutics

A fresh Form 4 filing shows Carl L. Gordon, a director of BlossomHill Therapeutics, Inc. (BLSM), purchased 625,000 shares of the company on the open market on August 10, 2026. The transaction, priced at $16.00 per share, totaled $10,000,000.00 — a purchase made with the insider’s own funds rather than acquired through options or other … Read more

BLSM Insider Buy: OrbiMed Advisors Spends $10M on Shares

Illustration of an SEC Form 4 filing document showing an insider stock purchase by OrbiMed Advisors LLC in BlossomHill Therapeutics

A director of BlossomHill Therapeutics, Inc. (BLSM) put real money on the table this week. According to a Form 4 filing, OrbiMed Advisors LLC purchased 625,000 shares of BlossomHill on August 10, 2026, in an open-market transaction priced at $16.00 per share. The total outlay came to an even $10,000,000.00, funded directly by the insider … Read more